Clinical trial
Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of…
NCT00485134 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00485134 |
|---|---|
| Title | Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection |
| Official title | Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | U.S. Army Office of the Surgeon General U.S. Fed |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Shigellosis |
| Intervention type | Biological, Other |
| Interventions | 240 µg Shigella flexneri 2a Invaplex 50 vaccine, 480 µg Shigella flexneri 2a Invaplex 50 vaccine, 690 Shigella flexneri 2a Invaplex 50 vaccine, Shigella challenge strain |
| Enrollment | 113 |
| Start date | May 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Sep 1, 2010 |
| First posted | Jun 12, 2007 |
| Last update posted | Sep 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: